benzbromarone has been researched along with Urolithiasis in 3 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
Urolithiasis: Formation of stones in any part of the URINARY TRACT, usually in the KIDNEY; URINARY BLADDER; or the URETER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Reports of acute kidney injury (AKI) associated with benzbromarone use in patients with hyperuricemia (HUA) are rare so far." | 7.91 | Benzbromarone as a possible cause of acute kidney injury in patients with urolithiasis: Two case reports. ( Li, W; Tang, K; Wu, J; Xiong, C; Ye, X; Zhuo, L, 2019) |
| "The object of this study was to evaluate the effect of uric acid lowering therapy in reducing the new development of comorbidities and the frequency of acute attacks in gout patients." | 7.80 | Prevention of comorbidity and acute attack of gout by uric acid lowering therapy. ( Joo, H; Joo, K; Jung, KH; Kwon, SR; Lim, MJ; Park, W, 2014) |
| "Reports of acute kidney injury (AKI) associated with benzbromarone use in patients with hyperuricemia (HUA) are rare so far." | 3.91 | Benzbromarone as a possible cause of acute kidney injury in patients with urolithiasis: Two case reports. ( Li, W; Tang, K; Wu, J; Xiong, C; Ye, X; Zhuo, L, 2019) |
| "The object of this study was to evaluate the effect of uric acid lowering therapy in reducing the new development of comorbidities and the frequency of acute attacks in gout patients." | 3.80 | Prevention of comorbidity and acute attack of gout by uric acid lowering therapy. ( Joo, H; Joo, K; Jung, KH; Kwon, SR; Lim, MJ; Park, W, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ye, X | 1 |
| Wu, J | 1 |
| Tang, K | 1 |
| Li, W | 1 |
| Xiong, C | 1 |
| Zhuo, L | 1 |
| Joo, K | 1 |
| Kwon, SR | 1 |
| Lim, MJ | 1 |
| Jung, KH | 1 |
| Joo, H | 1 |
| Park, W | 1 |
| Perez-Ruiz, F | 1 |
| Hernandez-Baldizon, S | 1 |
| Herrero-Beites, AM | 1 |
| Gonzalez-Gay, MA | 1 |
3 other studies available for benzbromarone and Urolithiasis
| Article | Year |
|---|---|
Benzbromarone as a possible cause of acute kidney injury in patients with urolithiasis: Two case reports.
Topics: Acute Kidney Injury; Adolescent; Benzbromarone; Humans; Hyperuricemia; Kidney; Male; Middle Aged; Se | 2019 |
Prevention of comorbidity and acute attack of gout by uric acid lowering therapy.
Topics: Adult; Allopurinol; Antimetabolites; Benzbromarone; Cardiovascular Diseases; Comorbidity; Diabetes M | 2014 |
Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with gout.
Topics: Allopurinol; Benzbromarone; Cohort Studies; Creatinine; Follow-Up Studies; Gout; Humans; Hyperuricem | 2010 |